Radiant Research, Inc., a leading provider of clinical and consumer product testing, has expanded its consumer division.
Radiant Research, Inc., a leading provider of clinical and consumer product testing, has expanded its consumer division. This expansion includes additional geographic locations and increased product testing capabilities. The changes give Radiant’s consumer testing sites the ability to conduct studies in more diverse dermatological disease states, as well as in a varied demographical healthy normal population, with new bioinstrumentation resources.
“Radiant has become an industry leader in complex consumer trials since launching this specialized division in 2011,” said Tara Kelley, vice president of operations for Radiant Research. “Now, we’re giving our clients more options for their consumer testing needs by adding new locations and specialty populations. We’ve also made the process more efficient by integrating our consumer product and clinical trial database – giving us access to one million potential study participants.”
As part of its commitment to safe, effective and efficient consumer product testing, Radiant Research staffs clinical coordinators, recruitment specialists, technicians and medical research specialists at each site. Additionally, the sites are supported by a central team of experienced professionals who provide resources that are unmatched in the industry.
In addition to the wide range of claim support studies, Radiant Research has expanded its Dermal Safety testing to include the following: Cumulative Irritation, Phototoxicity, Contact Sensitization, Primary Irritation, Photoallergy and Transdermal Delivery Systems at multiple locations.
Radiant Research encourages those with consumer product testing needs to visithttp://www.radiantresearch.com and contact Charley Folk at 480-699-3406 or [email protected].
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.